CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- Open-market buys, last 90 days
- $352,317
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Obrocea Mihail Chief Medical Officer | Grant or award · Stock Options | +87,495 | 87,495 | ||
| 2023-03-08 | Obrocea Mihail Chief Medical Officer | Grant or award · Stock Options | +100,000 | 100,000 |
Page 1 of 1 · 2 trades